REVIEW   

Minerva Endocrinologica 2020 December;45(4):376-80

DOI: 10.23736/S0391-1977.20.03390-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone

Martina CAPUZZO ¹, Valeria DONNO ¹, Antonio LA MARCA ^{1, 2} ✉

¹ Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy; ² Clinica EUGIN, Modena, Italy

The differential diagnosis of anovulatory disorders is actually based on serum gonadotrophin and estradiol levels. However, several other markers have been proposed. The purpose of this review was to underline the role of anti-Müllerian hormone (AMH) as a possible marker in differential diagnosis of the anovulatory diseases and its use as a predictive marker of prognosis. In this article we discuss clinical and experimental evidences actually existing in literature and we suggest new potential clinical application of AMH.

KEY WORDS: Anti-Müllerian hormone; Polycystic ovary syndrome; Amenorrhea; Menopause, premature